Switch to
More onapp

How to use scorecard? Learn more

Jubilant Pharmova Ltd

JUBLPHARMA
Health CarePharmaceuticals
SmallcapWith a market cap of ₹9,060 cr, stock is ranked 497
High RiskStock is 4.43x as volatile as Nifty
571.400.75 (-0.13%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Scorecard

Performance

Low

Hasn't fared well - amongst the low performers

Valuation

High

Seems to be overvalued vs the market average

Growth

Low

Lagging behind the market in financials growth

Profitability

High

Showing good signs of profitability & efficiency

Entry point

Avg

The stock is overpriced but is not in the overbought zone

Red flags

Low

No red flag found

How to use scorecard? Learn more

Health CarePharmaceuticals
SmallcapWith a market cap of ₹9,060 cr, stock is ranked 497
High RiskStock is 4.43x as volatile as Nifty

Key MetricsEdit

No LabelNo Label
239.68
PB RatioPB Ratio
1.68
Dividend YieldDiv. Yield
0.88%
Sector PESector PE
51.33
Sector PBSector PB
5.88
Sector Div YldSctr Div Yld
0.57%

Forecast & RatingsDetailed Forecast 

100%

Analysts have suggested that investors can buy this stock

Price

Price Upside

Pro Only

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Jubilant Life Sciences Limited is a pharmaceutical and life sciences company.

Brands

Jubilant Life Sciences

Pharmaceutical company

Investor PresentationView older 

May 29, 2023

PDF
View Older Presentations

Brands

Jubilant Life Sciences

Pharmaceutical company

Financial TrendFinancial statements 

20202021202220236.236.396.146.330.900.840.41-0.06
Revenue
Profit
Loss
All values in ₹ Thousand cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Increased Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has increased by 1.08%

See detailed holdings

Recent NewsAll news 

Hmm, looks like data is unavailable here. Please come back after some time
See all news

Recent EventsAll events 

Outcome of Board Meeting 
Announced OnMar 26, 2024

Jubilant Pharmova Limited has informed the Exchange regarding Outcome of Board Meeting held on March 26, 2024. | Download

Jubilant Pharmova Limited has informed the Exchange regarding Outcome of Board Meeting held on March 26, 2024. | Download

Trading Window-XBRL 
Announced OnMar 22, 2024

JUBILANT PHARMOVA LIMITED has informed the Exchange about Closure of Trading Window | Download

JUBILANT PHARMOVA LIMITED has informed the Exchange about Closure of Trading Window | Download

Cash Dividend 
Ex. DateAug 10, 2023

Final • Div/Share: ₹ 5

See all events